RLAB & MRES: RLAB Appoints Edward Akeroyd Hunt as Head of Investor Relations and Partnerships at M2MMA

$RLAB & $MRES: RLAB Appoints Edward Akeroyd Hunt as Head of Investor Relations and Partnerships at M2MMA to focus on expanding its capital network.

$RLAB & $MRES: RLAB Appoints Edward Akeroyd Hunt as Head of Investor Relations and Partnerships at M2MMA

DUBAI, UNITED ARAB EMIRATES – Real American Capital Corp (RLAB), trading as M2MMA, is pleased to announce the appointment of Edward Akeroyd Hunt as Head of Investor Relations and Partnerships. This strategic addition underscores M2MMA’s focus on expanding its capital network and global reach at a time of accelerating growth and innovation.

Edward is a graduate of NYU’s Sports Business Master’s Program and has held prior roles at S&P Global and IHS Markit. His academic and professional background reflects a deep interest in the intersection of finance, sport, and emerging technologies. At M2MMA, Edward will lead efforts to identify strategic investment opportunities, cultivate institutional relationships, and drive commercial expansion.

Edward Akeroyd Hunt joins M2MMA as Head of Investor Relations and Partnerships.

“Joining M2MMA is the right move at the right time,” said Edward. “This is a company with a real mission, combining sport, science, and innovation to elevate athlete performance and wellbeing. I’m looking forward to helping shape the investment narrative and building partnerships that align with our ambition and purpose.”

His appointment follows a series of milestone developments for M2MMA. The company recently announced a global partnership with Green Hill Sports to co-develop AI-integrated fight gear and appointed veteran broadcaster Andrew Whitelaw as Head of Media to enhance international visibility and digital engagement.

“We are delighted to welcome Ed as Head of Investor Relations during a critical phase of our evolution,” said Jeff Robinson, Chairman and CEO of M2MMA. “We are entering active discussions with sovereign, institutional, and retail investors across the Middle East, and Ed brings the professionalism and strategic focus we need to support this expansion. His leadership will help us strengthen our capital base and position the brand for long-term visibility and value.”
Edward will operate from the United States, working closely with senior leadership across M2MMA to support global investor engagement and strategic outreach.

About M2MMA: M2MMA is redefining combat sports by uniting real-time analytics, blockchain architecture, and elite athlete care into a single intelligent platform. Artificial intelligence converts live fight data into predictive safety systems and performance optimization tools, while blockchain ensures transparency, trust, and on-chain verification across all operations. With a leadership team deeply rooted in data science, systems design, and decentralized technologies, M2MMA is building a future where combat sports are safer, smarter, and more accountable, while maintaining a connection to the traditions that have shaped the sport.

The company is publicly traded on the Over-the-Counter Bulletin Board (OTCBB) of NASDAQ under the ticker symbol “RLAB.”
RLAB, operating as M2MMA, is majority owned by M2Bio Sciences, a publicly traded company listed on the Over-the-Counter market under the symbol MRES. Both RLAB and MRES are nearing completion of their Form 10 filings, with submissions expected shortly. The planned uplisting will enhance regulatory visibility and significantly increase investor awareness across both entities.

Forward-Looking Statements
Safe Harbour Statement – Besides historical information, this press release may contain forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team concerning the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that such forward-looking statements are not guarantees of future performance, involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, inability to realize improvements in performance, efficiency, and profitability, and adverse developments concerning litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that could cause results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility for updating any forward-looking statements.

Jeff Robinson
M2Bio Sciences Food and Beverage (Pty) Ltd
+27 72 333 2148
email us here
Visit us on social media:
LinkedIn
Instagram
Facebook
YouTube
TikTok
X